Insilico Begins Phase III Trial of AI-Designed IPF Therapy
CAMBRIDGE, Mass., July 7, 2026 Insilico Medicine has announced the initiation of its Phase III clinical trial evaluating Rentosertib,...
Small Molecule
Advertisement
Ambrosia Biosciences Raises $100M for GLP-1 Pipeline
BOULDER, Colo., USA — March 31, 2026 Ambrosia Biosciences Inc. has announced the successful completion of a $100 million...
FDA Grants Fast Track to AJ201 for Kennedy’s Disease Therapy
TAIPEI, Taiwan – October 23, 2025 AnnJi Pharmaceutical Co., Ltd. (AJ Pharm) announced that the U.S. Food and Drug...
Alzheimer’s and Eye Drug Updates Highlight InMed FY2025
Vancouver, BC, September 23, 2025 – InMed Pharmaceuticals has reported its full‐year fiscal 2025 financial results and provided a...
Advertisement
